SOLA2 AMF Knee System
Periprosthetic Joint Infection (PJI) of the knee
First-in-Human (under IDE)Active
Key Facts
Indication
Periprosthetic Joint Infection (PJI) of the knee
Phase
First-in-Human (under IDE)
Status
Active
Company
About Solenic Medical
Solenic Medical is developing a novel, non-invasive therapeutic platform targeting biofilm infections on metallic orthopedic implants, a major and costly surgical complication. Its lead investigational device, the SOLA2, has received FDA Investigational Device Exemption (IDE) approval, enabling First-in-Human clinical studies as of August 2024. The company is led by a seasoned executive team with deep experience in medical devices, orthopedics, and technology development, positioning it to address a significant unmet need in the growing joint replacement market.
View full company profile